Patent
   D358644
Priority
Jan 18 1994
Filed
Jan 18 1994
Issued
May 23 1995
Expiry
May 23 2009
Assg.orig
Entity
unknown
28
3
n/a
The ornamental design for a transponder implanter, as shown and described.

FIG. 1 is a perspective view showing my design;

FIG. 2 is a top plan view thereof;

FIG. 3 is a left side elevational view thereof, the right side elevational view being a mirror image thereof;

FIG. 4 is a front elevational view thereof;

FIG. 5 is a rear elevational view thereof; and,

FIG. 6 is a bottom plan view thereof.

Park, Chinsoo

Patent Priority Assignee Title
10159714, Feb 16 2011 Intarcia Therapeutics, Inc. Compositions, devices and methods of use thereof for the treatment of cancers
10231923, Sep 28 2009 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
10363287, Feb 03 2005 Intarcia Therapeutics, Inc. Method of manufacturing an osmotic delivery device
10441528, Feb 13 2008 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
10501517, May 16 2016 INTARCIA THERAPEUTICS, INC Glucagon-receptor selective polypeptides and methods of use thereof
10527170, Aug 09 2006 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies for use therein
10583080, Sep 30 2014 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
10835580, Jan 03 2017 INTARCIA THERAPEUTICS, INC Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
10869830, Sep 28 2009 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
10925639, Jun 03 2015 INTARCIA THERAPEUTICS INC Implant placement and removal systems
11214607, May 16 2016 Intarcia Therapeutics Inc. Glucagon-receptor selective polypeptides and methods of use thereof
11246913, Feb 03 2005 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
11654183, Jan 03 2017 Intarcia Therapeutics, Inc. Methods comprising continuous administration of exenatide and co-administration of a drug
11840559, May 16 2016 INTARCIA ASSIGNMENT FOR THE BENEFIT OF CREDITORS , LLC Glucagon-receptor selective polypeptides and methods of use thereof
7247160, Dec 30 2002 Varian Medical Systems, Inc Apparatuses and methods for percutaneously implanting objects in patients
9241660, Jun 08 2005 Senseonics, Incorporated Insertion device and method
9623208, Jan 12 2004 Varian Medical Systems, Inc Instruments with location markers and methods for tracking instruments through anatomical passageways
9889085, Sep 30 2014 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
D388171, Jun 23 1995 Roussel Uclaf Instrument for implantations for manual use
D634843, Feb 24 2009 EDGE SURGICAL, INC Handheld surgical depth instrument with rectangular body
D673679, Oct 19 2010 Lancet
D761424, Apr 16 2014 VIACYTE, INC Deployment tool for an encapsulation device
D835783, Jun 02 2016 Intarcia Therapeutics, Inc. Implant placement guide
D840030, Jun 02 2016 INTARCIA THERAPEUTICS INC Implant placement guide
D860451, Jun 02 2016 INTARCIA THERAPEUTICS INC Implant removal tool
D912249, Jun 02 2016 Intarcia Therapeutics, Inc. Implant removal tool
D933219, Jul 13 2018 Intarcia Therapeutics, Inc. Implant removal tool and assembly
ER418,
Patent Priority Assignee Title
3744493,
4787384, Oct 06 1986 BIO MEDIC DATA SYSTEM, INC , A NJ CORP Animal marker implanting system
5250026, May 27 1992 Digital Angel Corporation Adjustable precision transponder injector
//
Executed onAssignorAssigneeConveyanceFrameReelDoc
Dec 01 1993PARK, CHINSOOBIOMEDIC DATA SYSTEMS, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0068660201 pdf
Jan 18 1994Bio Medic Data Systems, Inc.(assignment on the face of the patent)
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule